- The purchase was completed in January 2022 and is estimated to have a value of one billion dollars.
- Now Metative plans to continue the use of technology focused on the field of health.
- His main lines of research are Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and imaging software offerings previously offered by IBM Watson Health.
The field of health innovation is in constant transformation due to all the benefits that technology offers. Similarly, business is very important for this sector because financial investments allow projects to continue. Thus, today the launch of Merativea new medical research company.
In that sense, everything goes back to January of this 2022 when the firm Francis Partners specified the acquisition of IBM Watson Health assets. This generated one of the largest negotiations in the history of the sanitation industry.
Although the details of the purchase were not published, some reports indicate that the transaction was worth at least one billion dollars. But now the important thing is to know why IBM WatsonHealth it is such a valuable business.
The power of applied technology in medical solutions
Watson’s natural language, hypothesis generation, and evidence-based learning capabilities are under investigation in healthcare to see how it can contribute to clinical decision support systems and the rise of artificial intelligence in the healthcare industry. health care for use by medical professionals.
All of the above led to the creation in 2011 of IBM WatsonHealth. It is a set of digital tools that helps facilitate medical research, clinical research, and healthcare services through the use of Artificial Intelligence, data, analytics, cloud computing, and other advanced information technologies.
While now, half a year after the purchase, the new owner of the company announced that will change its name to Merative. Headquartered in Ann Arbor, Michigan, it aims to offer its health data services to clients ranging from providers, health plans and employers to life sciences firms, imaging companies and government entities.
It was also announced that Merative will have six main product lines available from the start: Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and imaging software offerings previously offered by IBM Watson Health.
For its part, Technologies such as Artificial Intelligence are increasingly present in the field of health. Not only through the development of innovations but also within the clinics in daily activities.
Through its use, it has changed the doctor-patient relationship in several ways. For starters, it is now possible to analyze large amounts of data in a matter of seconds. There are already tools designed against high-mortality diseases such as breast cancer. From the information of each person it is possible to obtain a diagnosis of their risk.
The patient is the center of the strategy
In this context of development and innovation, there are other Artificial Intelligence tools that help improve the experience of patients through the Internet. For example, incorporating chatbots has benefits for both parties. First, advise patients to receive an immediate response. While for doctors it allows them to make appointments and avoid losing work.